Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 6 (RPSAP6) is a member of the RPSA gene family, which comprises one functional gene (RPSA) and numerous processed pseudogenes, including RPSAP6. Pseudogenes in this family are highly homologous to RPSA but contain disabling mutations such as frameshifts, premature stop codons, or lack of translation initiation sites, and therefore do not encode functional proteins. The functional RPSA protein is a multifunctional protein with ribosomal and cell-surface receptor roles, notably as a laminin receptor implicated in cancer, prion diseases, and viral infection, but no such functions are documented or expected for RPSAP6. There is no evidence that RPSAP6 is expressed as a protein or fulfills any known regulatory RNA function; it is classified simply as a genomic pseudogene[2][4][3].
Not applicable; RPSAP6 does not encode a functional molecule, so no drugs or mechanism of action are described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 6 (RPSAP6).